Eastwood Bio-Medical Canada Profit Margin

Eastwood Bio-Medical Canada's profit margin stands at -74.09% as of July 2024. That compares with -36.14% in the prior-year period — down 105.0% year over year. That is below the sector sector average of 13.09%. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Eastwood Bio-Medical Canada reported -74.09% in profit margin versus -36.14% a year earlier — a 105.0% year-over-year decrease. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

Eastwood Bio-Medical Canada sits lower the its sector benchmark (13.09%) with a profit margin of -74.09%. That is roughly 666.0% below the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.

A profit margin of -74.09% for Eastwood Bio-Medical Canada means each unit of related capital or sales is generating that return rate. Higher is usually better for profitability metrics, but extremely high figures can reflect one-time items or thin equity bases. Review several years of data on this page before extrapolating.

The history chart shows how Eastwood Bio-Medical Canada's profit margin evolved across reporting periods, while the comparison chart places EWOOF next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.